Turn Therapeutics Inc. (TTRX) Balance Sheet
As of 2026-06-30 (10-Q), Turn Therapeutics Inc. (TTRX) reported total assets of $17.0M, total liabilities of $16.3M and shareholders' equity of $686888, according to EquiReason's reading of its SEC filings. Cash and equivalents: $9.9M. Long-term debt: $6.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TTRXTurn Therapeutics Inc.Follow TTRX — free
—
Price chart with a free account
- Market cap
- 306.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 18 days
| Line | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|
| Cash and equivalents | 4.0 | 9.9 | |
| Current assets | 5.2 | 10.4 | |
| Total assets | 12.2 | 17.0 | |
| Current liabilities | 6.0 | 8.8 | |
| Long-term debt | — | 6.1 | |
| Total liabilities | 7.5 | 16.3 | |
| Shareholders' equity | 4.7 | 0.7 |
USD millions · SEC XBRL
Turn Therapeutics Inc. — questions
- How much cash does Turn Therapeutics Inc. have?
- $9.9M in cash and cash equivalents as of 2026-06-30.
- How much debt does Turn Therapeutics Inc. have?
- $6.1M of long-term debt as of 2026-06-30.
- What are Turn Therapeutics Inc.'s total assets?
- $17.0M as of 2026-06-30.
- What is Turn Therapeutics Inc.'s shareholders' equity?
- $686888 as of 2026-06-30.
Every figure on this page comes from Turn Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.